B-cell lymphomas | sciencenewsnet.in

Breaking News

MD Anderson launches Institute for Cell Therapy Discovery & Innovation to deliver transformational new therapies

Key Pathway Leading to Neurodegeneration in Early Stages of ALS Identified

Deep ocean clues to a million-year-old Ice Age puzzle revealed in new study

Deep Vein Thrombosis Affects 3% of Central Venous Catheters in NICU Patients

Maintaining “Good” Care: An Articulation Work Perspective on Organizational Ethics in the Healthcare Sector

Turning a Blind Eye to Team Members’ Unethical Behavior: The Role of Reward Systems

Number of Whooping Cough Cases on Rise Nationally

Religion in Family Firms: A Socioemotional Wealth Perspective on Top-Level Executives with Perceived Religiosity

Appealing to voters through podcasts, expert explains advantages

United Nations ratifies framework to protect people on cash apps

08 Nov, 2024

Some lymphomas become resistant to treatment. Gene discovery may offer path to overcome it.

March 15, 2024 sarah JonasResearch Results

Patients with some types of lymphoma that become resistant to standard treatments may benefit from a therapy that University of Wisconsin–Madison researchers are evaluating after they discovered a key process that fuels the blood cancers’ resistance to current drugs.

NCCN’s New Patient Guidelines for Marginal Zone Lymphoma Help Patients and Caregivers Better Understand a Rare Form of Blood Cancer

September 12, 2022 sarah JonasAnnouncement

The new patient guidelines for Marginal Zone Lymphoma guidelines are the latest in NCCN’s library of NCCN Guidelines for Patients®, published through funding from the NCCN Foundation® and available online free of charge.